Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Alamar Biosciences, Inc.NASDAQ: ALMR

EPS (Basic) · Q2 FY2026 · quarter ended Jun 2026

EPS (Basic) of -$0.22 in Q2 FY2026

Q2 FY2026 EPS (Basic) was -$0.22.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 3 analysts of -$1.4 (-211.6%) for the fiscal year ending Dec 2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-$0.22+29.0% QoQ
Last fiscal yearDec 2025
-$0.45— YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year—-211.6%—
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(0.45) USD
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 EPS (Basic) of -$0.45 is the 4th highest of the 9 companies compared; the peer median is -$0.49.
ALMR Competitors Peer median
EPS (Basic) for ALMR and competitors
Company Period LTM YoY 3-year CAGR
TECHBio-Techne CorporationLTM Sep 2026$1.1 +120.0%-13.5%
LABStandard BioTools Inc.LTM Mar 2026-$0.25 +28.4%—
PACBPacific Biosciences of California, Inc.LTM Mar 2026-$0.43 +81.2%—
ALMRAlamar Biosciences, Inc.FY2025-$0.45 ——
NAUTNautilus Biotechnology, Inc.LTM Mar 2026-$0.46 +14.8%—
QSIQuantum-Si incorporatedLTM Mar 2026-$0.51 +24.4%—
TXG10x Genomics, Inc.LTM Sep 2026-$0.52 +16.1%—
SEERSeer, Inc.LTM Mar 2026-$1.24 +10.8%—
TWSTTwist Bioscience CorporationLTM Sep 2026-$2.08 -60.0%—
Peer median (excluding ALMR) -$0.49+20.3%-13.5%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.